|本期目录/Table of Contents|

[1]王汝佳,鲍彦平.合成毒品使用人群中HIV 感染状态及危险因素研究进展[J].传染病信息,2017,06:346-350.
 WANG Ru-jia,BAO Yan-ping*.Research progress on HIV infection andassociated risk factors among synthetic drug users[J].Infectious Disease Information,2017,06:346-350.
点击复制

合成毒品使用人群中HIV 感染状态及危险因素研究进展(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2017年06期
页码:
346-350
栏目:
专题综述
出版日期:
2017-12-20

文章信息/Info

Title:
Research progress on HIV infection andassociated risk factors among synthetic drug users
作者:
王汝佳鲍彦平
100191,北京大学中国药物依赖性研究所(王汝佳、鲍彦平);100191,北京大学公共卫生学院(王汝佳)
Author(s):
WANG Ru-jia BAO Yan-ping*
National Institute on Drug Dependence, Peking University, 100191, China; School of Public Health, Peking University, 100191, China
关键词:
合成毒品HIV危险因素
Keywords:
synthetic drug HIV risk factors
分类号:
R512.91
DOI:
10.3969/j.issn.1007-8134.2017.06.008
文献标识码:
A
摘要:
合成毒品使用者中HIV 感染率的地区分布变化较大,注射使用合成毒品者及使用合成毒品的男男性接触者中HIV感染的风险较高。在合成毒品使用者中,未婚、无业者,多药滥用,注射使用毒品以及共用注射器等毒品使用行为,多性伴、无保护性行为、性交易及性暴力等不安全性行为以及合并感染多种疾病等因素为HIV 感染与传播的危险因素。加强禁毒力度,积极采取有针对性的干预和治疗措施,以期预防和减少HIV 在我国合成毒品滥用者中的感染与传播。
Abstract:
The prevalence of HIV infection among synthetic drug users has significant geographical variation. Injecting syntheticdrug users and man who have sex with man have a higher risk for HIV infection. Among synthetic drug users, the risk factors for HIVinfection and transmission include the unmarried, unemployed, drug abuse, injecting drug and sharing syringe, the unprotected sexualbehaviors such as multiple sexual partners, sexual transactions and sexual violence, co-morbidities. It is high time to promote the drugcontrol effect and take targeted intervention and treatment measures, in order to prevent and reduce HIV infection and transmissionamong synthetic drug users in China.

参考文献/References

[1] United Nations Office on Drugs and Crime. World Drug Report[R/OL].
[2017-11-05]. https://www.unodc.org/wdr2017/index.html.
[2] Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden ofdisease attributable to illicit drug use and dependence: findingsfrom the Global Burden of Disease Study 2010[J]. Lancet,2013, 382(9904):1564-1574.
[3] Degenhardt L, Hall W. Extent of illicit drug use and dependence,and their contribution to the global burden of disease[J]. Lancet,2012, 379(9810):55-70.
[4] Marshall BD, Werb D. Health outcomes associated withmethamphetamine use among young people: a systematic review[J].Addiction, 2010, 105(6):991-1002.
[5] 国家食品药品监督管理局. 2015 年国家药物滥用监测报告[R]. 北京:国家食品药品监督管理局,2016.
[6] Parry C, Petersen P, Carney T, et al. Rapid assessment of druguse and sexual HIV risk patterns among vulnerable drug-usingpopulations in Cape Town, Durban and Pretoria, South Africa[J].SAHARA J, 2008, 5(3):113-119.
[7] Wechsberg WM, Doherty IA, Myers B, et al. Contextualizinggender differences and methamphetamine use with HIV prevalencewithin a South African community[J]. Int J Drug Policy, 2014,25(3):583-590.
[8] Lorvick J, Bourgois P, Wenger LD, et al. Sexual pleasure andsexual risk among women who use methamphetamine: a mixedmethods study[J]. Int J Drug Policy, 2012, 23(5):385-392.
[9] Truong HM, Kellogg TA, McFarland W, et al. Sentinel surveillanceof HIV-1 transmitted drug resistance, acute infection and recentinfection[J]. PLoS One, 2011, 6(10):e25281.
[10] Bao YP, Liu ZM, Lian Z, et al. Prevalence and correlates of HIVand HCV infection among amphetamine-type stimulant users in6 provinces in China[J]. J Acquir Immune Defic Syndr, 2012,60(4):438-446.
[11] Liu D, Jiang Z, Xiu C, et al. Sexually transmitted infectionprevalence and related risk factors among heterosexual malemethamphetamine users in China[J]. Int J STD AIDS,2017:956462417693165.
[12] Beyrer C, Razak MH, Jittiwutikarn J, et al. Methamphetamine usersin northern Thailand: changing demographics and risks for HIV andSTD among treatment-seeking substance abusers[J]. Int J STDAIDS, 2004,15(10):697-704.
[13] Srirak N, Kawichai S, Vongchak T, et al. HIV infection amongfemale drug users in Northern Thailand[J]. Drug AlcoholDepend, 2005, 78(2):141-145.
[14] Celentano DD, Sirirojn B, Sutcliffe CG, et al. Sexually transmitted infections and sexual and substance use correlates among youngadults in Chiang Mai, Thailand[J]. Sex Transm Dis, 2008,35(4):400-405.
[15] Razak MH, Jittiwutikarn J, Suriyanon V, et al. HIV prevalenceand risks among injection and noninjection drug users in northernThailand: need for comprehensive HIV prevention programs[J].J Acquir Immune Defic Syndr, 2003, 33(2):259-266.
[16] Deiss RG, Lozada RM, Burgos JL, et al. HIV prevalence and sexualrisk behaviour among non-injection drug users in Tijuana, Mexico [J]. Glob Public Health, 2012, 7(2):175-183.
[17] Uhlmann S, DeBeck K, Simo A, et al. Health and social harmsassociated with crystal methamphetamine use among streetinvolvedyouth in a Canadian setting[J]. Am J Addict, 2014,23(4):393-398.
[18] Talu A, Rajaleid K, Abel-Ollo K, et al. HIV infection and riskbehaviour of primary fentanyl and amphetamine injectors inTallinn, Estonia: implications for intervention[J]. Int J DrugPolicy, 2010, 21(1):56-63.
[19] Zule WA, Costenbader EC, Meyer WJ Jr, et al. Methamphetamineuse and risky sexual behaviors during heterosexual encounters[J].Sex Transm Dis, 2007, 34(9):689-694.
[20] Kral AH, Lorvick J, Martinez A, et al. HIV prevalence and riskamong heterosexual methamphetamine injectors in California[J].Subst Use Misuse, 2011, 46(9):1081-1089.
[21] Harris NV, Thiede H, McGough JP, et al. Risk factors for HIVinfection among injection drug users: results of blinded surveys indrug treatment centers, King County, Washington 1988-1991[J].J Acquir Immune Defic Syndr, 1993, 6(11):1275-1282.
[22] Marshall BD, Shoveller JA, Wood E, et al. Difficulty accessingsyringes mediates the relationship between methamphetamine useand syringe sharing among young injection drug users[J]. AIDSBehav, 2011, 15(7):1546-1553.
[23] Kall KI, Olin RG. HIV status and changes in risk behaviour amongintravenous drug users in Stockholm 1987-1988[J]. AIDS,1990, 4(2):153-157.
[24] Blaxhult A, Janzon R, Bottiger M, et al. A six-year follow-upof HIV seroprevalence among 300 intravenous drug users inStockholm[J]. Scand J Infect Dis,1992, 24(6):715-723.
[25] Loxley WM, Marsh AM, Hawks DV, et al. HIV risk behaviouramong injecting drug users in Perth: the Australian NationalAIDS and Injecting Drug Use Study[J]. Med J Aust, 1992,156(10):687-692.
[26] Crofts N, Hopper JL, Milner R, et al. Blood-borne virus infectionsamong Australian injecting drug users: implications for spread ofHIV[J]. Eur J Epidemiol, 1994, 10(6):687-694.
[27] Peck JA, Shoptaw S, Rotheram-Fuller E, et al. HIV-associatedmedical, behavioral, and psychiatric characteristics of treatmentseeking,methamphetamine-dependent men who have sex with men [J]. J Addict Dis, 2005, 24(3):115-132.
[28] Plankey MW, Ostrow DG, Stall R, et al. The relationship betweenmethamphetamine and popper use and risk of HIV seroconversionin the multicenter AIDS cohort study[J]. J Acquir Immune DeficSyndr, 2007, 45(1):85-92.
[29] Halkitis PN, Levy MD, Solomon TM. Temporal relations betweenmethamphetamine use and HIV seroconversion in gay, bisexual,and other men who have sex with men[J]. J Health Psychol,2016, 21(1):93-99.
[30] Rudy ET, Shoptaw S, Lazzar M, et al. Methamphetamine useand other club drug use differ in relation to HIV status and riskbehavior among gay and bisexual men[J]. Sex Transm Dis,2009, 36(11):693-695.
[31] Xu JJ, Zhang C, Hu QH, et al. Recreational drug use and risks ofHIV and sexually transmitted infections among Chinese men whohave sex with men: Mediation through multiple sexual partnerships [J]. BMC Infect Dis, 2014, 14:642.
[32] Xu JJ, Qian HZ, Chu ZX, et al. Recreational drug use amongChinese men who have sex with men: a risky combination withunprotected sex for acquiring HIV infection[J]. Biomed Res Int,2014, 2014:725361.
[33] Burcham JL, Tindall B, Marmor M, et al. Incidence and risk factorsfor human immunodeficiency virus seroconversion in a cohort ofSydney homosexual men[J]. Med J Aust, 1989, 150(11):634-639.
[34] Lea T, Mao L, Bath N, et al. Injecting drug use among gay andbisexual men in Sydney: prevalence and associations with sexualrisk practices and HIV and hepatitis C infection[J]. AIDSBehav, 2013, 17(4):1344-1351.
[35] Vu NT, Holt M, Phan HT, et al. Amphetamine-type stimulant useamong men who have sex with men (MSM) in Vietnam: Results froma socio-ecological, community-based study[J]. Drug AlcoholDepend, 2016, 158:110-117.
[36] Robertson AM, Syvertsen JL, Ulibarri MD, et al. Prevalence andcorrelates of HIV and sexually transmitted infections amongfemale sex workers and their non-commercial male partners in twoMexico-USA border cities[J]. J Urban Health, 2014, 91(4):752-767.
[37] 樊盼英,王增强,王俊杰. 北京地区部分新型毒品滥用者HIV/STIs 感染现状调查[J]. 中国艾滋病性病,2010,5:485-488.
[38] 鲍彦平,王同瑜. 我国五地区合成毒品滥用者中海洛因多药滥用特征及相关因素分析[J]. 中国药物依赖性杂志,2015,24(6):450-460.
[39] 初平,贾忠伟. 云南省苯丙胺类兴奋剂滥用及其与HIV/STD感染相关因素的研究[J]. 中国药物依赖性杂志,2012,21(6):451-458.
[40] Giese C, Igoe D, Gibbons Z, et al. Injection of new psychoactivesubstance snow blow associated with recently acquired HIVinfections among homeless people who inject drugs in Dublin,Ireland, 2015[J]. Euro Surveill, 2015, 20(40).
[41] Suntharasamai P, Martin M, Vanichseni S, et al. Factors associatedwith incarceration and incident human immunodeficiency virus(HIV) infection among injection drug users participating in an HIVvaccine trial in Bangkok, Thailand, 1999-2003[J]. Addiction,2009, 104(2):235-242.
[42] 刘铁桥,郝伟. 苯丙胺类兴奋剂概介[J]. 国外医学精神病学分册,2001,28(3):129-134.
[43] 刘志民. 氯胺酮滥用及其导致的公共卫生和社会问题[J]. 中国药物依赖性杂志,2016,25(1):2-10.
[44] Drumright LN, Little SJ, Strathdee SA, et al. Unprotected analintercourse and substance use among men who have sex with menwith recent HIV infection[J]. J Acquir Immune Defic Syndr,2006, 43(3):344-350.
[45] Colfax G, Santos GM, Chu P, et al. Amphetamine-group substancesand HIV[J]. Lancet, 2010, 376(9739):458-474.
[46] Jia Z, Wang W, Dye C, et al. Exploratory analysis of the associationbetween new-type drug use and sexual transmission of HIV inChina[J]. Am J Drug Alcohol Abuse, 2010, 36(2):130-133.
[47] 刘春,黄民主. 男女吸毒者吸毒特点、性行为特点与HBV、HCV 重叠感染关系的研究[J]. 现代医院,2005,5(3):12-14.
[48] 王艳芬,张玉竹,连智. 北京地区三种新型毒品流行滥用特征[J]. 中国药物依赖性杂志,2008,17(6):444-454.
[49] 冯理智,蔡卫平,胡凤玉. HIV/HCV 合并感染的相互影响及抗病毒治疗研究进展[J]. 传染病信息,2014,27(6):333-336,384.

备注/Memo

备注/Memo:
[基金项目] 国家“十三五”重点研发计划(2016YFC0800907)
[通信作者] 鲍彦平,E-mail: baoyp@bjmu.edu.cn
更新日期/Last Update: 2017-12-20